RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-843
Malaria parasiteP. yoelii
Genotype
MutatedGene model (rodent): PY17X_0719200; Gene model (P.falciparum): PF3D7_0417100; Gene product: mRNA-binding protein PUF2 (Pumilio2)
Details mutation: A puf2 gene lacking the N-terminal region but containing the RNA-binding domain with an 4xMyc tag
PhenotypeNo phenotype has been described
Last modified: 14 March 2013, 17:15
  *RMgm-843
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 23356439
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii 17XNL
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherLindner SE; Kappe SH
Name Group/DepartmentSeattle Biomedical Research Institute
Name InstituteSeattle Biomedical Research Institute
CitySeattle
CountryUS
Name of the mutant parasite
RMgm numberRMgm-843
Principal namePuf2-RBDmyc
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
The mutant  expresses a mutated form of of the RNA binding protein Puf2.
The predominant feature of Puf2 is its RNA binding domain (RBD), which is comprised of eight canonical RNA recognition helices. The mutated Puf2 lacks the N-terminal domain by fusing the Puf2 5′ UTR (including its start codon) to the predicted RBD and spans all four exons (AA132-478). The N-terminal portion of Puf2 (AA1-131) has no predicted PFAM domains, nor any significant similarity/identity to non-orthologous proteins. The mutated Puf2 also contains a C-terminal 4x Myc tag to the RBD.

Protein (function)
The roles of Puf (Pumilio and fem-3 mRNA binding factor) proteins are diverse yet intimately involved in the translational regulation of developmental and differentiation factors in organisms as diverse as yeast, C. elegans, Drosophila and humans. Two such proteins, Puf1 (PFE0935c) and Puf2 (PFD0825c), are known in the human malaria parasite, P. falciparum, with orthologs in all Plasmodium spp. characterized. The Plasmodium Puf proteins have the typical highly conserved organization that includes the eight tandem copies of the PUM RNA binding domain (or Pumilio Homology Domain, PHD) at the carboxyterminus of the protein and expectedly PfPuf2 was shown to bind RNA in vitro. In P. falciparum evidence has been reported for a role for Puf2 in gametocyte development although Pfpuf2 is most highly transcribed in sporozoites.
Analysis of P. berghei RMgm-515, RMgm-516, RMgm-617) and P. yoelii (RMgm-842) mutants lacking expression of Puf2 indicate that  Puf2 regulates the transition of sporozoites into liver stage forms.

Phenotype
Analysis of P. berghei RMgm-515, RMgm-516, RMgm-617) and P. yoelii (RMgm-842) mutants lacking expression of Puf2 indicate that  Puf2 regulates the transition of sporozoites into liver stage forms. Sporozoites lacking expression of Puf2 show reduced infectivity.

Analysis of the mutant expressing the mutated form of Puf2 indicates that  the RNA binding domain (RBD) is necessary and sufficient for all essential Puf2 functions, and parasites that express only the RBD retain normal infectivity and exhibit no phenotypic defects.

Additional information
By analysis of  Puf2 localisation in sporozoites evidence is presented that Puf2 traffics to sporozoite cytosolic granules, which are negative for several markers of stress granules and P-bodies, and disappear rapidly after infection of hepatocytes.
RNAseq analyses provided evidence for a role of Puf2 in directly or indirectly maintaining the homeostasis of specific transcripts in sporozoites.

Other mutants
P. berghei mutants that lack expression of Puf2: RMgm-515, RMgm-516, RMgm-617)
RMgm-842: a P. yoelii mutant lacking expression of Puf2


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PY17X_0719200
Gene Model P. falciparum ortholog PF3D7_0417100
Gene productmRNA-binding protein PUF2
Gene product: Alternative namePumilio2
Details of the genetic modification
Short description of the mutationA puf2 gene lacking the N-terminal region but containing the RNA-binding domain with an 4xMyc tag
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationGene targeting constructs for transgenic parasite production were designed as previously described with some modifications (Mikolajczak et al., 2008a). Briefly, two regions of the targeted locus were PCR amplified. The two PCR products were fused by Sequence Overlap Extension PCR (“SOE PCR”) by virtue of complementary sequences designed into the primers.
This SOE PCR product (“targeting sequence”) was digested at the 5’ and 3’ ends via exogenous
restriction sites designed in the primers and inserted into a modified pDEF vector designed for genetic disruptions or for gene modifications by locus replacement via double-crossover recombination.

Targeting sequences designed to express only the RNA-Binding Domain of Puf2 (“Puf2-RBDmyc”, AA132-478) were produced by an additional SOE PCR event to seamlessly fuse the promoter with the coding sequence without an intervening restriction enzyme site.

Here, the correctly annotated wild-type locus was genetically modified by double-crossover recombination with a plasmid that seamlessly fused Puf2’s 5’UTR (with its start codon) to its RNA-Binding Domain (RBD) with an appended C-terminal 4xMyc tag (“Puf2-RBDmyc”)

Prior to transfection, plasmids were linearized at unique restriction sites designed between the two halves of the targeting sequences
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1GCCGCGGCATGTACATGTGCATACAAAAAGTGGACACACTTGTATG
Additional information primer 13'-Fwd
Sequence Primer 2GCTAGTTATGGGGCCCAGCTAGCGTGTGTATGTATGCATGTATGTAGAGAGGGAAATG
Additional information primer 23'-Rev (SOE)
Sequence Primer 3CACACGCTAGCTGGGCCCCATAACTAGCAAAATAGCGAAATGACATAACAAAACGACAAC
Additional information primer 35'-Fwd (SOE)
Sequence Primer 4CATTGATTGGTTGTTCATTCATCGTTTTTGGGTATACTTAAATGTATATATATACCCGTA
Additional information primer 45'-Rev (SOE)
Sequence Primer 5AAGTATACCCAAAAACGATGAATGAACAACCAATCAATGAAATATTAGAAAACACAAAGG
Additional information primer 5RBD-Fwd (SOE)
Sequence Primer 6GGACTAGTTGACTCTAAATTGTTAATAGCTCTTAAAATATATTTACCTATAAAACATGG
Additional information primer 6RBD-Rev